Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Hypersensitivity

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,456 public trials 324 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids

NCT00971035

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids

NCT00930163

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma

NCT01248975

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Pleven, Bulgaria

GSK Investigational Site Rousse, Bulgaria

GSK Investigational Site Varna, Bulgaria

GSK Investigational Site Bialystok, Poland

View all 19 locations

View Trial Details

Completed

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

NCT00806754

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Altana/Nycomed Encinitas, California, United States

Altana/Nycomed Los Angeles, California, United States

Altana/Nycomed Mission Viejo, California, United States

Altana/Nycomed San Diego, California, United States

View all 35 locations

View Trial Details

Completed

GSK2190915 Neutrophilic Asthma Study

NCT01471665

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Glasgow, Lanarkshire, United Kingdom

View Trial Details

Completed

Emergency Department (ED)-Directed Interventions to Improve Asthma Outcomes

NCT01079000

Conditions: Acute Asthma, Asthma, Bronchial Diseases, +12 more
Locations: University of Calgary Calgary, Alberta, Canada

University of Alberta Edmonton, Alberta, Canada

View Trial Details

Completed

Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

NCT00482248

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma

NCT00785083

Conditions: Asthma, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +12 more
Locations: Novartis Investigator Site Manchester, United Kingdom

View Trial Details

Completed

A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

NCT01804400

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: Novartis Investigative Site Hanover, Germany

View Trial Details

Completed

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

NCT00784732

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Novartis Investigator Site Toronto, Canada

View Trial Details